Welcome to Markets Desk, your midday read on what's moving and why.
SoftBank is taking a serious hit in Asian trading, falling ten percent as semiconductor and technology stocks across the region tracked overnight losses on Wall Street. The selloff reflects renewed pressure on high-multiple tech names, and SoftBank's heavy exposure to that sector makes it a bellwether for broader risk sentiment in Asia.
Shifting to corporate strategy, Starbucks is reportedly exploring options for its Japan business, including a potential stake sale. Japan is one of Starbucks' most significant international markets, and any transaction there would carry real valuation weight. This comes as incoming leadership continues its operational and portfolio review, signaling the company isn't ruling out structural changes to sharpen its global focus.
On the capital markets side, Tango Therapeutics priced an upsized public offering at thirty dollars per share, raising six hundred million dollars in total. The fact that underwriters pushed the deal larger than originally planned suggests institutional demand held firm, a meaningful signal for a clinical-stage oncology name that needs runway to advance its precision medicine pipeline through trials.
That's the tape. Markets Desk, signing off the floor.
